Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for IFN Alpha Signature in SLE
NCT00710021Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Nov 2008
- Primary completion
- Jul 2011
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in systemic lupus erythematosus (SLE), sponsored by National Institute of Allergy and Infectious Diseases. Started Nov 2008; status: completed.
02
Drugs
vitamin d
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00710021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00710021.